- Home
- FBIZ vs NMRA Comparison
FBIZ vs NMRA Comparison
Compare FBIZ & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIZ
- NMRA
- Stock Information
- Founded
- FBIZ 1909
- NMRA 2019
- Country
- FBIZ United States
- NMRA United States
- Employees
- FBIZ N/A
- NMRA N/A
- Industry
- FBIZ Major Banks
- NMRA
- Sector
- FBIZ Finance
- NMRA
- Exchange
- FBIZ Nasdaq
- NMRA Nasdaq
- Market Cap
- FBIZ 390.3M
- NMRA 424.4M
- IPO Year
- FBIZ N/A
- NMRA 2023
- Fundamental
- Price
- FBIZ $52.61
- NMRA $2.29
- Analyst Decision
- FBIZ Buy
- NMRA Buy
- Analyst Count
- FBIZ 3
- NMRA 8
- Target Price
- FBIZ $59.67
- NMRA $7.57
- AVG Volume (30 Days)
- FBIZ 21.9K
- NMRA 1.9M
- Earning Date
- FBIZ 10-30-2025
- NMRA 11-06-2025
- Dividend Yield
- FBIZ 2.27%
- NMRA N/A
- EPS Growth
- FBIZ 30.77
- NMRA N/A
- EPS
- FBIZ 6.07
- NMRA N/A
- Revenue
- FBIZ $158,054,000.00
- NMRA N/A
- Revenue This Year
- FBIZ $18.35
- NMRA N/A
- Revenue Next Year
- FBIZ $7.96
- NMRA N/A
- P/E Ratio
- FBIZ $8.41
- NMRA N/A
- Revenue Growth
- FBIZ 12.70
- NMRA N/A
- 52 Week Low
- FBIZ $42.18
- NMRA $0.61
- 52 Week High
- FBIZ $56.46
- NMRA $11.57
- Technical
- Relative Strength Index (RSI)
- FBIZ 55.45
- NMRA 45.34
- Support Level
- FBIZ $49.36
- NMRA $2.10
- Resistance Level
- FBIZ $52.98
- NMRA $2.78
- Average True Range (ATR)
- FBIZ 1.11
- NMRA 0.22
- MACD
- FBIZ 0.05
- NMRA -0.09
- Stochastic Oscillator
- FBIZ 69.29
- NMRA 20.56
About FBIZ First Business Financial Services Inc.
First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.